[go: up one dir, main page]

WO2010068815A3 - Compositions et procédés pour traiter des troubles prolifératifs cellulaires - Google Patents

Compositions et procédés pour traiter des troubles prolifératifs cellulaires Download PDF

Info

Publication number
WO2010068815A3
WO2010068815A3 PCT/US2009/067580 US2009067580W WO2010068815A3 WO 2010068815 A3 WO2010068815 A3 WO 2010068815A3 US 2009067580 W US2009067580 W US 2009067580W WO 2010068815 A3 WO2010068815 A3 WO 2010068815A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
proliferative disorders
cellular proliferative
treating cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/067580
Other languages
English (en)
Other versions
WO2010068815A2 (fr
Inventor
Hideaki Hagiwara
Kumiko Hagiwara
Takaaki Hagiwara
Yasunobu Takeshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HIHIMSA FOUNDATION
Original Assignee
HIHIMSA FOUNDATION
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HIHIMSA FOUNDATION filed Critical HIHIMSA FOUNDATION
Publication of WO2010068815A2 publication Critical patent/WO2010068815A2/fr
Publication of WO2010068815A3 publication Critical patent/WO2010068815A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/742—Coffea, e.g. coffee
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions et des procédés pour traiter des troubles prolifératifs cellulaires par administration d'une combinaison de fucoïdane et d'extraits antioxydants naturels. La présente invention concerne en outre des compositions comprenant un fucoïdane et un ou plusieurs extraits antioxydants naturels.
PCT/US2009/067580 2008-12-12 2009-12-10 Compositions et procédés pour traiter des troubles prolifératifs cellulaires Ceased WO2010068815A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12229308P 2008-12-12 2008-12-12
US61/122,293 2008-12-12
US18158409P 2009-05-27 2009-05-27
US61/181,584 2009-05-27

Publications (2)

Publication Number Publication Date
WO2010068815A2 WO2010068815A2 (fr) 2010-06-17
WO2010068815A3 true WO2010068815A3 (fr) 2010-10-28

Family

ID=42243319

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/067580 Ceased WO2010068815A2 (fr) 2008-12-12 2009-12-10 Compositions et procédés pour traiter des troubles prolifératifs cellulaires

Country Status (1)

Country Link
WO (1) WO2010068815A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110250259A1 (en) * 2010-04-12 2011-10-13 Kevin Buckman Method of treating and preventing breast diseases and breast cancer with medicated formula
CN101912408B (zh) * 2010-06-24 2013-03-20 首都医科大学 褐藻多糖硫酸酯在制备预防和治疗糖尿病血管疾病药物中的应用
US20130022663A1 (en) * 2011-07-19 2013-01-24 Vars Inc Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula
CN103239472B (zh) * 2013-05-10 2015-09-02 首都医科大学 褐藻多糖硫酸酯的药物用途
AU2015222697B2 (en) * 2014-02-26 2019-07-25 Deakin University Xanthone-rich plant extracts or compounds therefrom for modulating diseases of the central nervous system and related disorders
CN107580497A (zh) * 2015-02-16 2018-01-12 克桑蒂亚尔 用于预防或治疗皮肤病症的组合物
CN106727668A (zh) * 2016-12-17 2017-05-31 浙江工业大学 一种岩藻多糖在制备pc‑12细胞或mkn‑45细胞活性抑制剂中的应用
JP6818913B2 (ja) * 2017-02-09 2021-01-27 アルトリーゲン・カンパニー・リミテッドＡｌｔｒｅｇｅｎ Ｃｏ．，Ｌｔｄ． 人参／紅参及びナマコ複合抽出物を有効成分とするブルッフ膜機能の低下関連病気の予防又は治療用組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070224215A1 (en) * 2006-03-22 2007-09-27 Kevin Buckman Brown seaweed extracts in capsules consisting of broad-spectrum freeze dried antioxidant concentrates, Fucoidan, crystalloidals, Mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin C, and black pepper extract with delivery systems for utilization of nutrients
US20080089941A1 (en) * 2006-06-01 2008-04-17 Mower Thomas E Fucoidan compositions and methods
KR20080051523A (ko) * 2006-12-06 2008-06-11 전홍일 지방세포 분화 억제용 식품 첨가물
US20080254135A1 (en) * 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070224215A1 (en) * 2006-03-22 2007-09-27 Kevin Buckman Brown seaweed extracts in capsules consisting of broad-spectrum freeze dried antioxidant concentrates, Fucoidan, crystalloidals, Mangosteen, hyaluronic acid, alpha lipoic acid, green tea extract, vitamin C, and black pepper extract with delivery systems for utilization of nutrients
US20080089941A1 (en) * 2006-06-01 2008-04-17 Mower Thomas E Fucoidan compositions and methods
KR20080051523A (ko) * 2006-12-06 2008-06-11 전홍일 지방세포 분화 억제용 식품 첨가물
US20080254135A1 (en) * 2007-04-10 2008-10-16 Marvin Heuer Resveratrol-containing compositions for general health and vitality

Also Published As

Publication number Publication date
WO2010068815A2 (fr) 2010-06-17

Similar Documents

Publication Publication Date Title
WO2008124660A3 (fr) Procédés et compositions pour le traitement du cancer
PH12017500930A1 (en) Hsp90 inhibitor combinations
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2010065491A3 (fr) Procédés de traitement de troubles inflammatoires
WO2011130302A3 (fr) Procédés de traitement de l'obésité utilisant des modulateurs d'inflammation antioxydants
WO2008147797A3 (fr) Modulateurs de canal ionique et leurs procédés d'utilisation
WO2009089494A3 (fr) Compositions pharmaceutiques
WO2009120810A3 (fr) Troubles neurodégénératifs
WO2007084857A3 (fr) Procédés et compositions de traitement de troubles prolifératifs cellulaires
WO2012024620A3 (fr) Inhibiteurs de l'autotaxine et leurs utilisations
WO2011016840A3 (fr) Procédés et compositions de traitement de troubles de répétition tri-nucléotidique
WO2010068815A3 (fr) Compositions et procédés pour traiter des troubles prolifératifs cellulaires
WO2009089260A3 (fr) Combinaison d'anticorps anti-ctla4 avec des agents de modulation de la tubuline pour le traitement de maladies prolifératives
WO2007145704A3 (fr) Thérapie de combinaison de gemcitabine
WO2009158719A3 (fr) Méthodes et compositions de traitement de troubles
WO2011031896A3 (fr) Inhibiteurs de pi3 kinase et leurs utilisations
WO2011142858A3 (fr) Variants de la chlorotoxine, conjugués, et leurs méthodes d'utilisation
WO2011129936A3 (fr) Compositions et procédés pour la prévention et le traitement du cancer
WO2008005358A3 (fr) Antioxydants macromoléculaires innovants comprenant des fragments antioxydants différents : structures, procédés de fabrication et d'utilisation
WO2009117335A3 (fr) Inhibiteurs des récepteurs s1 p3 pour le traitement de l'inflammation
WO2010121164A3 (fr) Composés de 1,4-benzodiazépinone et leur utilisation dans le traitement du cancer
WO2010066639A3 (fr) Compositions d'éclaircissement de la peau avec des inhibiteurs d'acétylcholinestérase
WO2009009417A3 (fr) Compositions pharmaceutiques et procédés pour prévenir, traiter ou inhiber des maladies, des troubles ou des affections inflammatoires cutanés et des maladies, des troubles ou des affections associés à un appauvrissement en collagène
WO2011079307A3 (fr) Méthodes et compositions pour traiter des troubles neurologiques
WO2009035634A3 (fr) Cyanoaminoquinolones et tétrazoloaminoquinolones en tant qu'inhibiteurs de gsk-3

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09832574

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09832574

Country of ref document: EP

Kind code of ref document: A2